he latest report by IMARC Group, titled “Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the gene expression analysis market report. The report also includes competitor and regional analysis, and contemporary advancements in the market. the global gene expression analysis market size reached US$ 4.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2027, exhibiting a growth rate (CAGR) of 10.79% during 2022-2027. Gene expression analysis is extensively used across clinical, research and pharmaceutical settings to study individual genes, gene pathways, or greater gene activity profiles. It extracts data from a gene and investigates the activity of the biological system from the coding gene to detect a change in the expression pattern. Consisting of processes, such as gene transcription, translation, post-translational protein modification and RNA splicing, this method is used for synthesizing functional gene products, including functional RNA species and protein products. The analysis of gene regulation also aids in the proper understanding of normal cellular processes to enhance the functionality of the existing diagnostic methods and assist in the development of new drugs. As a result, this method finds extensive applications in pharmacogenomics, biomarking and toxicology.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally-our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/gene-expression-analysis-market/requestsample
Global Gene Expression Analysis Industry Trends:
The global market is primarily driven by the rising demand for personalized medicines, along with the increasing prevalence of chronic diseases. Understanding a patient’s unique molecular and genetic profile is crucial to the adoption of personalized medicines for the treatment of numerous ailments. Gene expression analysis aids in the modification of diagnostic methods, which vary according to the patient’s requirement. Moreover, declining prices of genetic sequencing has led to the growing adoption of sequencing in clinical applications, which is catalyzing the market growth. The low-cost availability of Next Generation Sequencing (NGS) technology, coupled with its high-speed performance and precise results, is also contributing to the market growth. Enhanced focus toward the adoption of advanced healthcare systems and modern diagnostics procedures, extensive research and development (R&D) in the field of gene therapy, and favorable government initiatives, including the Precision Medicine Initiative (PMI) by the United States Food and Drug Administration (US FDA) are some of the other factors that are projected to spur the market growth further.
Competitive Landscape with Key Players:
- Agilent Technologies, Inc.
- BGI Genomics Co., Ltd.
- Bio-Rad Laboratories, Inc.
- Eurofins GSC Lux SARL
- Hoffmann-La Roche Ltd
- GE Healthcare
- Llumina, Inc.
- Oxford Gene Technology IP Limited
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- QIAGEN GmbH
- Thermo Fisher Scientific Inc.
Breakup by Products & Services:
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- DNA Microarray
- Sanger Sequencing
Breakup by Capacity:
- Low-to Mid-Plex Gene Expression Analysis
- High-Plex Gene Expression Analysis
Breakup by End-User:
- Pharmaceutical and Biotech Companies
- Academic Institutes and Research Centers
Breakup by Region:
- North America Europe
- Asia Pacifi
- Latin America
- Middle East and Africa.
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800